A study in the New England Journal of Medicine published on November 5 shows that suPAR reliably can predict the development of Chronic Kidney Disease up to five years before symptoms of this disease emerge - a disease that affects an estimated 600 million people.

Come and meet us at the following Emergency Medicine Conferences - and hear about the Quantitative suPARnostic® Quick Triage product!

MD Gethin Hodges from Glostrup Hospital, Denmark, was elected for a moderated poster presentation at the ESC Congress 2015, European Society of Cardiology in London, with his poster titled;

In the latest issue of DSKB Nyt no. 2/2015, Dansk Selskab for Klinisk Biokemi, is an article on suPAR - a new prognostic biomarker in clinical routine at Copenhagen University Hospital, Hvidovre, Denmark.

Come and hear the poster presentation about suPAR and CVD by MD Gethin Hodges (Glostrup Hospital, Denmark) at the ESC2015 Conference (European Society of Cardiology) in London, August 29 - September 2.

The suPARnostic® Quick Triage is now a fully Quantitative Test for suPAR levels between
2-16 ng/mL suPAR.

The quantitative results are read with the suPARnostic® Quick Test Reader – available in only 
20 minutes.

Come and meet us at the following Emergency Medicine Conferences

The Swedish Medical University Karolinska Institutet, Stockholm South General Hospital/Södersjukhuset, KI SÖS, and Helsinki University Central Hospital, HUCH, supported by ViroGates will initiate a pivotal ambulance study to explore the use of suPARnostic® in a new method for prehospital patient assessment.

Come and meet us at the following Nordic Emergency meetings, where we will be present together with our Nordic distributor Electra-box Diagnostica:

March 16-17: SWEET 2015 - National meeting of Swedish Society for Emergency Medicine and the Nordic Federation of Emergency Meeting in Stockholm, Sweden.

Visit us at booth no. 7 where we will be running demos of the suPARnostic® Quick Triage product.

ViroGates A/S, the leading provider of products for triaging patients in acute care, today announced the appointment of Lars Kongsbak and Bernd Uder as new members of the Board of Directors.

Effective immediately, the new Board of Directors will consist of Lars Kongsbak, who will serve as chairman, Bernd Uder and Jørgen Thorball.

Join us at the 24th Winter Symposium of Emergency Medicine and Intensive Care in Karpacz, Poland!

The Symposium will take place on February 25-28, 2015.

Please find more information in the invitation here.

Our distributor Biomedica will be representing suPARnostic at their booth.

Hear the oral presentation by Dr. Jesper Eugen-Olsen, Hvidovre Hospital, Denmark:

"Implementation of suPAR in clinical routine: Association with disease severity, readmission, and mortality in the acute medical patient"

The presentation will take place in Panel Session 3 on Friday, Feb. 27th between 9:00-11:00.

Review the program in the following link.

76 new articles on suPAR were published in PubMed in 2014.

Thus we can now celebrate more than 330 publications in total on suPARnostic® * being a prognostic biomarker for survival in various diseases such as Cardiovascular diseases, Infectious diseases, Inflammation, Sepsis, Nephrology conditions, different Cancers, Diabetes, etc.